Hims & Hers Misses Third-Quarter Profit Forecast, Shares Slide

Telehealth platform Hims & Hers Health reported third-quarter 2026 profit below its own forecast, after which the company's shares declined. Investors are concerned about margin pressure, uncertainty around the revision of the forecast, and regulatory issues surrounding compounded GLP-1 medications.

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.